Rather, our study suggests that the assessment of TWIST2 expression, particularly in node-positive oral cavity/pharynx tumors, might help in identifying those cases that are at higher risk of fatal progression, pointing to TWIST2 as a potential marker. Here, TWIST2 is linked to pharynx neoplasm.